ethosuximide has been researched along with nickel in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barrionuevo, G; Henze, DA; Urban, NN | 1 |
| Chen, CC; Cheng, JK; Chiou, LC; Lin, CS; Yang, JR | 1 |
| Chang, YF; Chen, YL; Cheng, JK; Hung, YC; Lin, CS; Shiue, SJ; Tsaur, ML; Wang, SW; Wang, TY; Wang, YC | 1 |
3 other study(ies) available for ethosuximide and nickel
| Article | Year |
|---|---|
Amplification of perforant-path EPSPs in CA3 pyramidal cells by LVA calcium and sodium channels.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Anticonvulsants; Calcium Channel Blockers; Calcium Channels; Electric Stimulation; Ethosuximide; Excitatory Amino Acid Agonists; Excitatory Postsynaptic Potentials; Hippocampus; Ion Channel Gating; Male; Neural Pathways; Nickel; Nifedipine; Perforant Pathway; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Sodium Channels; Tetrodotoxin | 1998 |
Effects of intrathecal injection of T-type calcium channel blockers in the rat formalin test.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, T-Type; Disease Models, Animal; Dose-Response Relationship, Drug; Ethosuximide; Formaldehyde; Hindlimb; Injections, Spinal; Long-Term Potentiation; Male; Mibefradil; Neural Inhibition; Neuronal Plasticity; Nickel; Nociceptors; Pain Threshold; Rats; Rats, Sprague-Dawley; Spinal Cord | 2007 |
Chronic intrathecal infusion of mibefradil, ethosuximide and nickel attenuates nerve ligation-induced pain in rats.
Topics: Animals; Anticonvulsants; Calcium Channel Blockers; Disease Models, Animal; Ethosuximide; Ligation; Male; Mibefradil; Neuralgia; Nickel; Rats; Rats, Sprague-Dawley | 2015 |